SBIR/STTR Research Award
STABLE SUPPRESSION OF GENE FUNCTION IN MAMMALS BY RNAI
Award amount
$707,990Program and phase
SBIR · Phase IIAward year
2002Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- GENETICA, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): Cultured mammalian cells are the most
commonly used model organisms, both in academic and in industrial biology.
However, the tools that are available for manipulating these cells have been
relatively primative compared to those available in other model organisms, such
as C. elegans and Drosophila. It has been the primary mission of Genetica to
develop technologies that improve the ability to manipulate mammalian cells in
culture. A collateral benefit of such studies will also be improved
technologies to manipulate mammalian model organisms. Genetica has developed a
suite of tools, the MaRX system, which enable forward genetics to be harnessed
to address numerous biological problems in cell culture. However, to date, we
have most often used this system for rescue of phenotypes by ectopic
expression. The goal of this proposal is to develop the ability to use
double-stranded RNA-induced gene silencing (RNAi) as a tool for stable
suppression of gene function in mammalian cells. This goal is strongly rooted
in promising preliminary data that predicts the ultimate success of this
endeavor. Such success would revolutionize the ability of investigators
studying mammalian cells to determine gene function and would thus have
profound affects on the identification and validation of potential therapeutic
targets.
PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE
Technology keywords
Not reported